Can a gout drug protect heart bypass patients?
NCT ID NCT05726019
First seen Mar 10, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tested whether the anti-inflammatory drug colchicine can reduce common complications after coronary artery bypass surgery in people who recently had a heart attack. One hundred patients were randomly assigned to receive colchicine or a placebo for 30 days after surgery. The goal was to see if the drug lowers the risk of post-surgery heart issues like irregular heartbeat, heart attack, or inflammation around the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Heart Institute - University of São Paulo
São Paulo, São Paulo, 05403000, Brazil
Conditions
Explore the condition pages connected to this study.